scholarly journals Bendamustine-induced rash is associated with a favorable prognosis in patients with indolent B-cell lymphoma

2021 ◽  
Author(s):  
Naoki Takahashi ◽  
Kunihiro Tsukasaki ◽  
Ken Tanae ◽  
Mika Kohri ◽  
Chie Asou ◽  
...  
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Favorable Prognosis

A randomized trial of CHOP chemotherapy with or without melatonin in patients with favorable prognosis large B-cell lymphoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8066-8066
Author(s):  
A. Sarma ◽  
M. A. Rodriguez ◽  
F. Cabanillas ◽  
N. H. Dang ◽  
P. McLaughlin ◽  
...  
Keyword(s):  
B Cell ◽  
Randomized Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Chop Chemotherapy ◽  
Favorable Prognosis ◽  
Large B Cell Lymphoma ◽  
Large B Cell

A randomized trial of CHOP chemotherapy with or without melatonin in patients with favorable prognosis large B-cell lymphoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8066-8066 ◽  
Author(s):  
A. Sarma ◽  
M. A. Rodriguez ◽  
F. Cabanillas ◽  
N. H. Dang ◽  
P. McLaughlin ◽  
...  
Keyword(s):  
B Cell ◽  
Randomized Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Chop Chemotherapy ◽  
Favorable Prognosis ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

2010 ◽  
Vol 51 (9) ◽  
pp. 1643-1648 ◽  
Author(s):  
Karin Rydström ◽  
Johan Linderoth ◽  
Heidi Nyman ◽  
Mats Ehinger ◽  
Patrick Joost ◽  
...  
Keyword(s):  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Favorable Prognosis ◽  
Large B Cell Lymphoma ◽  
Potential Marker ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document